Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus. (Q54535403)

31 May 2018

title

Reduction in IL-33 expression exaggerates ischaemia/reperfusion-induced myocardial injury in mice with diabetes mellitus. (English)

1 reference

31 May 2018

author name string

Tao Rui

1

1 reference

31 May 2018

Jinchao Zhang

2

1 reference

31 May 2018

Xuemei Xu

3

1 reference

31 May 2018

Yongwei Yao

4

1 reference

31 May 2018

Raymond Kao

5

1 reference

31 May 2018

Claudio M Martin

6

1 reference

31 May 2018

publication date

18 January 2012

1 reference

31 May 2018

published in

Cardiovascular Research

1 reference

31 May 2018

volume

94

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

370-378

1 reference

31 May 2018

cites work

Epidemiology of diabetes

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Metabolism, hypoxia and the diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

The IL-33/ST2 pathway: therapeutic target and novel biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Activation of protein kinase C isoforms and its impact on diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Endothelial nitric oxide synthase (NOS3) knockout decreases NOS2 induction, limiting hyperoxygenation and conferring protection in the postischemic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

HMGB1: the missing link between diabetes mellitus and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Hyperglycaemia-induced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

PKCbeta modulates ischemia-reperfusion injury in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Cardiac-specific overexpression of HIF-1{alpha} prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVS015

21 January 2018

Identifiers

DOI

10.1093/CVR/CVS015

1 reference

31 May 2018

1 reference

31 May 2018